AbCellera Biologics Inc
ABCL
ISIN null / Valor 58489933
AbCellera Biologics Inc
UMushroom community rating:
About company
AbCellera Biologics Inc. is a biotechnology firm specializing in the discovery and development of antibody-based drugs. The company leverages its proprietary technologies to identify novel antibody candidates for a range of diseases, with a particular focus on creating potential first-in-class and best-in-class antibody medicines. AbCellera's approach includes the development of T-cell engagers for cancer treatment and antibodies targeting transmembrane proteins for various conditions such as metabolic and endocrine disorders, pain, autoimmunity, and more. Through both its internal pipeline and partnerships with other companies that offer novel science or innovative technology, AbCellera aims to accelerate the delivery of innovative medicines to patients. The company's efforts in developing a diverse array of fully human CD3-binding antibodies for T-cell engagers highlight its commitment to advancing the field of immunotherapy and addressing the limitations of current clinical developments.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
991 M
Market cap (USD)
2,369,182
Daily traded volume (Shares)
2.95 / 2.795
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Marcel Oenning
EQUITIES OF THE SAME SECTOR
